# Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

> **NCT04265105** · PHASE2,PHASE3 · COMPLETED · sponsor: **Royal College of Surgeons in Ireland - Medical University of Bahrain** · enrollment: 18 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone-vilanterol
- **DRUG:** Standard Preparation

## Key facts

- **NCT ID:** NCT04265105
- **Lead sponsor:** Royal College of Surgeons in Ireland - Medical University of Bahrain
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-22
- **Primary completion:** 2023-01-18
- **Final completion:** 2023-01-18
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04265105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04265105, "Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04265105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*